Author: Martyna Ramančiuckaitė Theme: „Pituitary adenomas postoperative treatment outcomes: postoperative complications and endocrine outcomes“ Pituitary adenomas are benign tumors that constitute approximately 10-15% intracranial and 85-91% of all sellar tumors [1,3]. Recent studies made in the latest year shows surgical treatment of pituitary adenomas outcomes around the world. The aim of this study is to evaluate frequency of postoperative complications and endocrinological outcomes for patients who underwent pituitary adenomas surgery during the period of 2007-2014. We evaluated frequency of endocrinological axis disturbance, estimated postoperative complications and evaluated factors influencing distant postoperative complications occu...
OBJECTIVE: Recovery from preexisting hypopituitarism after transsphenoidal surgery for pituitary ade...
OBJECTIVE: Recovery from preexisting hypopituitarism after transsphenoidal surgery for pituitary ade...
Contains fulltext : 190805.pdf (Publisher’s version ) (Open Access)BACKGROUND: It ...
Introduction:Considering the unique anatomical location and important role of pituitary gland in reg...
Objectives: To determine early postoperative complications of endoscopic endonasal transs...
Background: Little is known about possible predictors for hormonal function following pituitary surg...
Background: The aim of this study was to establish the rates of postoperative complications after tr...
Introduction: Pituitary adenomas are commonly benign, slow-growing tumors that arise from cells in t...
Introduction The outcome for pituitary endocrine function following endoscopic transsphenoidal surg...
Pituitary adenoma is a biologically benign tumour growing from the anterior part of pituitary gland ...
Objective: To determine the frequency of early post-operatively complications of transnasal transsph...
OBJECTIVE: Recovery from preexisting hypopituitarism after transsphenoidal surgery for pituitary ade...
BACKGROUND: Endoscopic endonasal (EE) transsphenoidal surgery is an important surgical approach to t...
BACKGROUND: Endoscopic endonasal (EE) transsphenoidal surgery is an important surgical approach to t...
Introduction: Surgery is still the initial treatment of choice to for the majority of date with pitu...
OBJECTIVE: Recovery from preexisting hypopituitarism after transsphenoidal surgery for pituitary ade...
OBJECTIVE: Recovery from preexisting hypopituitarism after transsphenoidal surgery for pituitary ade...
Contains fulltext : 190805.pdf (Publisher’s version ) (Open Access)BACKGROUND: It ...
Introduction:Considering the unique anatomical location and important role of pituitary gland in reg...
Objectives: To determine early postoperative complications of endoscopic endonasal transs...
Background: Little is known about possible predictors for hormonal function following pituitary surg...
Background: The aim of this study was to establish the rates of postoperative complications after tr...
Introduction: Pituitary adenomas are commonly benign, slow-growing tumors that arise from cells in t...
Introduction The outcome for pituitary endocrine function following endoscopic transsphenoidal surg...
Pituitary adenoma is a biologically benign tumour growing from the anterior part of pituitary gland ...
Objective: To determine the frequency of early post-operatively complications of transnasal transsph...
OBJECTIVE: Recovery from preexisting hypopituitarism after transsphenoidal surgery for pituitary ade...
BACKGROUND: Endoscopic endonasal (EE) transsphenoidal surgery is an important surgical approach to t...
BACKGROUND: Endoscopic endonasal (EE) transsphenoidal surgery is an important surgical approach to t...
Introduction: Surgery is still the initial treatment of choice to for the majority of date with pitu...
OBJECTIVE: Recovery from preexisting hypopituitarism after transsphenoidal surgery for pituitary ade...
OBJECTIVE: Recovery from preexisting hypopituitarism after transsphenoidal surgery for pituitary ade...
Contains fulltext : 190805.pdf (Publisher’s version ) (Open Access)BACKGROUND: It ...